Ivy Riano, MD

Articles by Ivy Riano, MD

Adopting Broader Clinical Trial Eligibility in Lung Cancer With Brain Mets, Leptomeningeal Disease

November 6th 2024

Ivy Riano, MD, of Dartmouth Geisel School of Medicine, discusses the adoption of broader clinical trial eligibility in lung cancer, specifically for those with brain metastases or leptomeningeal disease.

Ivy Riano, MD, thoracic oncologist, assistant professor, medicine, Dartmouth Cancer Center, Dartmouth Hitchcock Medical Center Dartmouth Geisel School of Medicine

Clinical Trial Education Is Essential in Hematology and Oncology Fellowship Curricula

ByIvy Riano, MD

October 23rd 2024

Many early-career clinicians are not familiarized with clinical trials during their training, so the opportunity to educate future trialists is hindered.

Ivy Riano, MD

Articles by Ivy Riano, MD

Adopting Broader Clinical Trial Eligibility in Lung Cancer With Brain Mets, Leptomeningeal Disease

Clinical Trial Education Is Essential in Hematology and Oncology Fellowship Curricula

Latest Updated Articles

Trending on OncLive

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma

Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma